Article Name Medtech
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed: AiMeD
01st August, 2023
- Advanced visualization and AI leader TeraRecon, a ConcertAI company, announced a strategic partnership with ClariPi, an innovative medical imaging AI company, to integrate ClariPi's solutions into its Eureka platform. With this partnership, TeraRecon continues to expand its offerings to enhance clinical workflows, delivering comprehensive medical imaging AI solutions to customers worldwide.
28th July, 2023
Opportunity for broader impact as 70% of key opinion leaders interact with only one biopharma
27th July, 2023
Validation of the mechanism of its enhancing effect on human work performance by measuring brain function
27th July, 2023
The new manufacturing plant will commence operations by March 2025
26th July, 2023
With an exceptional track record of 28 years in the industry
26th July, 2023
eparation enhances Company focus on Pharmaceutical and MedTech Research & Development to deliver innovative and differentiated health outcomes
25th July, 2023
Novel SaMD technology generates a 3D model of uterus to facilitate treatment in patients with symptomatic uterine fibroids
25th July, 2023
Making heat therapy more convenient and accessible
24th July, 2023
Jess Ng, Country Head of Singapore and Brunei at Fortinet, unravels best practices to mitigate cyber security risks in the healthcare, clinical and pharma ecosystem
24th July, 2023
In a Livestreamed Real-World Assessment, MedGPT's AI Doctors Rival Diagnostic Accuracy of China's Leading Doctors
24th July, 2023
Aevice Health, a leading provider of remote respiratory monitoring solutions for the healthcare continuum and backed by the Cedars-Sinai Accelerator, announced that its flagship medical device, the AeviceMD, has received clearance from the U.S. Food and Drug Administration (FDA) as a Class II medical device under the 510(k) route.
21st July, 2023
Selected by the National Center for Global Health and Medicine under the Ministry of Health, Labour and Welfare, Japan as "Projects for Global Growth of Medical Technologies, in 2023"
21st July, 2023
Strengthening medical systems business structure to accelerate growth
20th July, 2023
Transforming Heart Failure Management: Astellas, Eko Health & Welldoc Collaborate
19th July, 2023
Marks a departure from traditional liquid reagent-based testing methods
19th July, 2023
Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments.
18th July, 2023
Cutting-edge technology and high throughput production capacity mark a new milestone in radiation protection gloves manufacturing
18th July, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer